Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adults

Journal of Clinical Virology

Volumn 93, Issue , 2017, Pages 30-36

  Illiaquer, Marina ^a   Imbert Marcille, Berthe Marie ^a,b   Guillaume, Thierry ^a   Planche, Lucie ^a   Rimbert, Marie ^a   Bressollette Bodin, Céline ^a,b   Le Bourgeois, Amandine ^a   Peterlin, Pierre ^a   Garnier, Alice ^a   Le Houerou, Claire ^a   Moreau, Philippe ^a   Mohty, Mohamad ^a   Chevallier, Patrice ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

CMV; Cord blood transplant; EBV; HHV 6; PBSC; Reduced intensity

Indexed keywords

VIRUS DNA;

ADENOVIRIDAE; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; BK VIRUS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REDUCED INTENSITY CONDITIONING; UMBILICAL CORD BLOOD; VIRUS INFECTION; ALLOTRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; EXANTHEMA SUBITUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE RECONSTITUTION; IMMUNOLOGY; MIDDLE AGED; OPPORTUNISTIC INFECTION; POLYOMAVIRUS INFECTION; YOUNG ADULT;

ADULT; AGED; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE RECONSTITUTION; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; POLYOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 85020267443     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2017.05.019     Document Type: Article

References (47)

1. Ballen, K.K., Gluckman, E., Broxmeyer, H.E., Umbilical cord blood transplantation: the first 25 years and beyond. Blood, 122, 2013, 491.
2. Danby, R., Rocha, V., Improving engraftment and immune reconstitution in umbilical cord blood transplantation. Front. Immunol., 5, 2014, 68.
3. Parody, R., Martino, R., Rovira, M., et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol. Blood Marrow Transplant., 12, 2006, 734.
4. Ljungman, P., de la Camara, R., Cordonnier, C., et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant., 42, 2008, 227.
5. Styczynski, J., Reusser, P., Einsele, H., et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant., 43, 2009, 757.
6. Agut, H., Bonnafous, P., Gautheret-Dejean, A., Laboratory and clinical aspects of human herpesvirus 6 infections. Clin. Microbiol. Rev., 28, 2015, 313.
7. Ljungman, P., Hakki, M., Boeckh, M., Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol. Oncol. Clin. North Am., 25, 2011, 151.
8. Peric, Z., Cahu, X., Chevallier, P., et al. Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Leukemia, 25, 2011, 932.
9. Silva, L. de P., Patah, P.A., Saliba, R.M., et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica, 95, 2010, 1183.
10. Robin, M., Marque-Juillet, S., Scieux, C., et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica, 92, 2007, 1254.
11. Chevallier, P., Hebia-Fellah, I., Planche, L., et al. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant., 45, 2010, 1204.
12. Yamane, A., Mori, T., Suzuki, S., et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol. Blood Marrow Transplant., 13, 2007, 100.
13. Scheurer, M.E., Pritchett, J.C., Amirian, E.S., Zemke, N.R., Lusso, P., Ljungman, P., HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant., 48, 2012, 574.
14. Hill, J.A., Koo, S., Guzman Suarez, B.B., et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol. Blood Marrow Transplant., 18, 2012, 1638.
15. Jeulin, H., Agrinier, N., Guery, M., et al. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation. Transplantation, 95, 2013, 1292.
16. Blaise, D., Castagna, L., Do different conditioning regimens really make a difference?. Hematol. Am. Soc. Hematol. Educ. Program., 2012, 2012, 237.
17. Bacigalupo, A., Ballen, K., Rizzo, D., et al. Defining the intensity of conditioning regimens: working definitions. Biol. Blood Marrow Transplant., 15, 2009, 1628.
18. Glucksberg, H., Storb, R., Fefer, A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 1974, 295.
19. Matthes-Martin, S., Feuchtinger, T., Shaw, P.J., et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl. Inf. Dis., 14, 2012, 555.
20. Dropulic, L.K., Jones, R.J., Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant., 41, 2008, 11.
21. Gautheret-Dejean, A., Manichanh, C., Thien-Ah-Koon, F., et al. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J. Virol. Methods, 100, 2002, 27.
22. Bressollette-Bodin, C., Coste-Burel, M., Besse, B., André-Garnier, E., Ferre, V., Imbert-Marcille, B.-M., Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy. J. Med. Virol., 81, 2009, 90.
23. Bressollette-Bodin, C., Coste-Burel, M., Hourmant, M., Sebille, V., Andre-Garnier, E., Imbert-Marcille, B.M., A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am. J. Transplant., 5, 2005, 1926.
24. Heim, A., Ebnet, C., Harste, G., Pring-Akerblom, P., Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol., 70, 2003, 228.
25. Oudin, C., Chevallier, P., Furst, S., et al. Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies. Haematologica, 99, 2014, 1762.
26. Chevallier, P., Labopin, M., Socié, G., et al. Results from a clofarabine-busulfan containing reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase II prospective CLORIC trial. Haematologica 99:September (9) (2014), 1486–1491.
27. Brunstein, C.G., Barker, J.N., Weisdorf, D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood, 110, 2007, 3064.
28. Ponce, D.M., Sauter, C., Devlin, S., et al. A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation. Biol. Blood Marrow Transplant., 19, 2013, 799.
29. Le Bourgeois, A., Mohr, C., Guillaume, T., et al. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis. Biol. Blood Marrow Transplant., 19, 2013, 934.
30. Peffault de Latour, R., Brunstein, C.G., Porcher, R., et al. Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia. Biol. Blood Marrow Transplant. 19 (2013), 1355–1360.
31. Illiaquer, M., Malard, F., Guillaume, T., et al. Long-lasting HHV-6 reactivation in long-term adult survivors after double umbilical cord blood allogeneic stem cell transplantation. J. Infect. Dis., 210, 2014, 567.
32. Tang, H., Serada, S., Kawabata, A., et al. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc. Natl. Acad. Sci. U. S. A., 110, 2013, 9096.
33. Imbert-Marcille, B.M., Tang, X.W., Lepelletier, D., et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin. Infect. Dis., 31, 2000, 881.
34. Boutolleau, D., Fernandez, C., André, E., et al. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J. Infect. Dis., 187, 2003, 179.
35. Dulery, R., Salleron, J., Dewilde, A., et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. Biol. Blood Marrow Transplant., 18, 2012, 1080.
36. de Pagter, P.J.A., Schuurman, R., Keukens, L., et al. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT Bone Marrow. Transplant 48:November (11) (2013), 1460–1464.
37. Pascal, L., Tucunduva, L., Ruggeri, A., et al. Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation. Blood, 126, 2015, 1027.
38. Olson, A.L., Dahi, P.B., Zheng, J., et al. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biol. Blood Marrow Transplant., 20, 2014, 787.
39. Crough, T., Khanna, R., Immunobiology of human cytomegalovirus: from bench to bedside. ClinMicrobiol Rev, 22, 2009, 76.
40. Walker, C.M., van Burik, J.-A.H., De For, T.E., Weisdorf, D.J., Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol. Blood Marrow Transplant., 13, 2007, 1106.
41. Matsumura, T., Narimatsu, H., Kami, M., et al. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biol. Blood Marrow Transplant., 13, 2007, 577.
42. Gaziev, J., Paba, P., Miano, R., et al. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol. Blood Marrow Transplant., 16, 2010, 662.
43. Brunstein, C.G., Weisdorf, D.J., DeFor, T., et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood, 108, 2006, 2874.
44. Papadopoulou, A., Gerdemann, U., Katari, U.L., et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci. Transl. Med., 2014, a83.
45. Kanda, J., Chiou, L.-W., Szabolcs, P., et al. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol. Blood Marrow Transplant., 18, 2012, 1664.
46. Jacobson, C.A., Turki, A.T., McDonough, S.M., et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol. Blood Marrow Transplant., 18, 2012, 565.
47. Le Bourgeois, A., Lestang, E., Guillaume, T., et al. Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT). Eur. J. Haematol., 90, 2013, 177.